Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ast-opc1 (1 trial)
grnvac1 (1 trial)
grnopc1 (1 trial)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Spinal Cord Injuries (Phase 2)
Spinal Injuries (Phase 2)
Wounds and Injuries (Phase 2)
Trials (3 total)
Trial APIs (3 total)